- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/062 - Dipeptides the side chain of the first amino acid being acyclic, e.g. Gly, Ala
Patent holdings for IPC class C07K 5/062
Total number of patents in this class: 914
10-year publication summary
|
90
|
90
|
84
|
63
|
85
|
56
|
60
|
64
|
65
|
39
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Biohaven Therapeutics Ltd. | 121 |
16 |
| Albireo AB | 176 |
13 |
| Bristol-myers Squibb Company | 4742 |
12 |
| Dana-Farber Cancer Institute, Inc. | 2664 |
12 |
| Nissan Chemical Industries, Ltd. | 1645 |
11 |
| Allergan, Inc. | 2167 |
10 |
| Cornell University | 3425 |
9 |
| MedImmune Limited | 610 |
9 |
| Arvinas Operations, Inc. | 261 |
9 |
| Case Western Reserve University | 1889 |
8 |
| ImmunoGen, Inc. | 379 |
8 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 383 |
8 |
| Hoffmann-La Roche Inc. | 3793 |
7 |
| Siemens Medical Solutions USA, Inc. | 1463 |
7 |
| Ambrx, Inc. | 170 |
7 |
| Helsinn Healthcare SA | 228 |
7 |
| On Target Laboratories, LLC | 32 |
7 |
| Ono Pharmaceutical Co., Ltd. | 421 |
7 |
| Evonik Operations GmbH | 4362 |
7 |
| Changchun Genescience Pharmaceutical Co., Ltd. | 142 |
7 |
| Other owners | 733 |